Blood count recovery after decitabine-primed induction. Box plots showing the median (line), interquartile (box extents), and range (whiskers) of WBC (A,D,G), ANC (B,E,H), and platelet count (C,F,I) for responding subjects (CR or PR) enrolled on the phase 1 study. Each row of panels represent subjects treated at the dose level labeled on left: Level 1, 3 days of decitabine (A-C); Level 2, 5 days of decitabine (D-F); and Level 3, 7 days of decitabine (G-I). The dashed lines represent the extents of the normal range. Blood count data are summarized daily between days −3 and +21. Days earlier than day 3 are binned. Between day 22 through day 30, data were binned every 2 days and after day 30, 5-day bins were used. Day +1 is indicated with a vertical gray line.